Literature DB >> 17064843

Supraspinal site of action for the inhibition of ejaculatory reflex by dapoxetine.

Pierre Clément1, Jacques Bernabé, Peter Gengo, Pierre Denys, Miguel Laurin, Laurent Alexandre, François Giuliano.   

Abstract

OBJECTIVES: The aim of the study was to determine whether dapoxetine, a short-acting selective serotonin reuptake inhibitor, acts at the spinal or supraspinal level to inhibit the ejaculatory reflex.
METHODS: The pudendal motoneuron reflex discharges (PMRDs) model was used as an experimental paradigm of the ejaculatory expulsion reflex in anaesthetised male rats. A spinal site of action was evaluated by testing the effect of intrathecal delivery of dapoxetine on PMRDs elicited by electric stimulation of the dorsal nerves of the penis (DNP). A supraspinal site of action was evaluated by testing the effect of intravenous administration of dapoxetine on DNP-induced PMRDs in rats with chemical bilateral lesion of the lateral paragigantocellular nucleus (LPGi).
RESULTS: Compared with control (NaCl 0.9%, intrathecally), intrathecal injection of dapoxetine (1 and 80 microg) significantly increased amplitude of DNP-elicited PMRDs in a similar fashion than serotonin (5-HT; 10 and 100 microg, intrathecally). In rats having received bilaterally NaCl 0.9% into LPGi, intravenous treatment with dapoxetine (3mg/kg) induced significant delay in PMRD latency and decrease in PMRD amplitude compared with pretreatment values. These effects were abolished in rats having received bilaterally kainic acid into LPGi 1 d before testing.
CONCLUSIONS: The present study showed that dapoxetine inhibits ejaculatory expulsion reflex by acting at a supraspinal level with LPGi as a necessary brain structure for this effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17064843     DOI: 10.1016/j.eururo.2006.10.011

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  11 in total

1.  Premature ejaculation: definition and drug treatment.

Authors:  François Giuliano
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Dapoxetine: a new option in the medical management of premature ejaculation.

Authors:  Chris G McMahon
Journal:  Ther Adv Urol       Date:  2012-10

Review 3.  Dapoxetine: in premature ejaculation.

Authors:  Sheridan M Hoy; Lesley J Scott
Journal:  Drugs       Date:  2010-07-30       Impact factor: 9.546

4.  Serotonergic lesions of the periaqueductal gray, a primary source of serotonin to the nucleus paragigantocellularis, facilitate sexual behavior in male rats.

Authors:  Joseph J Normandin; Anne Z Murphy
Journal:  Pharmacol Biochem Behav       Date:  2011-02-03       Impact factor: 3.533

5.  Excitotoxic lesions of the nucleus paragigantocellularis facilitate male sexual behavior but attenuate female sexual behavior in rats.

Authors:  J J Normandin; A Z Murphy
Journal:  Neuroscience       Date:  2010-12-07       Impact factor: 3.590

Review 6.  Somatic genital reflexes in rats with a nod to humans: anatomy, physiology, and the role of the social neuropeptides.

Authors:  Joseph J Normandin; Anne Z Murphy
Journal:  Horm Behav       Date:  2011-02-19       Impact factor: 3.587

Review 7.  Normal male sexual function: emphasis on orgasm and ejaculation.

Authors:  Amjad Alwaal; Benjamin N Breyer; Tom F Lue
Journal:  Fertil Steril       Date:  2015-09-16       Impact factor: 7.329

8.  Efficacy of dapoxetine in the treatment of premature ejaculation.

Authors:  Chris G McMahon
Journal:  Clin Med Insights Reprod Health       Date:  2011-08-02

9.  Emerging treatments for premature ejaculation: focus on dapoxetine.

Authors:  Wayne J G Hellstrom
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

Review 10.  Dapoxetine and the treatment of premature ejaculation.

Authors:  Premsant Sangkum; Rhamee Badr; Ege Can Serefoglu; Wayne J G Hellstrom
Journal:  Transl Androl Urol       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.